BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26948040)

  • 1. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design.
    Wang F; Chen C; Tan W; Yang K; Yang H
    Sci Rep; 2016 Mar; 6():22677. PubMed ID: 26948040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the inhibition of the HCoV-NL63 main protease M
    Xu J; Zhu Q; Li W; Yin X; Li J
    Biochem Biophys Res Commun; 2024 Sep; 724():150231. PubMed ID: 38852502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63.
    Chen Z; Wang Y; Ratia K; Mesecar AD; Wilkinson KD; Baker SC
    J Virol; 2007 Jun; 81(11):6007-18. PubMed ID: 17392370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of human coronavirus NL63 main protease at different pH values.
    Gao H; Zhang Y; Jiang H; Hu X; Zhang Y; Zhou X; Zhong F; Lin C; Li J; Luo J; Zhang J
    Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):348-355. PubMed ID: 34605439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
    Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
    J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1.
    Zhao Q; Li S; Xue F; Zou Y; Chen C; Bartlam M; Rao Z
    J Virol; 2008 Sep; 82(17):8647-55. PubMed ID: 18562531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
    Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
    J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
    Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q
    Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age.
    Lee J; Storch GA
    Pediatr Infect Dis J; 2014 Aug; 33(8):814-20. PubMed ID: 24577040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of human coronavirus NL63 infection and replication.
    Castillo G; Mora-Díaz JC; Breuer M; Singh P; Nelli RK; Giménez-Lirola LG
    Virus Res; 2023 Apr; 327():199078. PubMed ID: 36813239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan.
    Huang SH; Su MC; Tien N; Huang CJ; Lan YC; Lin CS; Chen CH; Lin CW
    J Microbiol Immunol Infect; 2017 Dec; 50(6):763-770. PubMed ID: 26746130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design.
    Xue X; Yu H; Yang H; Xue F; Wu Z; Shen W; Li J; Zhou Z; Ding Y; Zhao Q; Zhang XC; Liao M; Bartlam M; Rao Z
    J Virol; 2008 Mar; 82(5):2515-27. PubMed ID: 18094151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Characterization of Human Coronavirus NL63 N Protein.
    Szelazek B; Kabala W; Kus K; Zdzalik M; Twarda-Clapa A; Golik P; Burmistrz M; Florek D; Wladyka B; Pyrc K; Dubin G
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implications.
    Chaudhuri R; Tang S; Zhao G; Lu H; Case DA; Johnson ME
    J Mol Biol; 2011 Nov; 414(2):272-88. PubMed ID: 22004941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Action of Tryptanthrin Isolated from
    Tsai YC; Lee CL; Yen HR; Chang YS; Lin YP; Huang SH; Lin CW
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32120929
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
    Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
    J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63.
    Dijkman R; Jebbink MF; Deijs M; Milewska A; Pyrc K; Buelow E; van der Bijl A; van der Hoek L
    J Gen Virol; 2012 Sep; 93(Pt 9):1924-1929. PubMed ID: 22718567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Croup is associated with the novel coronavirus NL63.
    van der Hoek L; Sure K; Ihorst G; Stang A; Pyrc K; Jebbink MF; Petersen G; Forster J; Berkhout B; Uberla K
    PLoS Med; 2005 Aug; 2(8):e240. PubMed ID: 16104827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
    Wang H; Xue S; Yang H; Chen C
    Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.
    Weng JR; Lin CS; Lai HC; Lin YP; Wang CY; Tsai YC; Wu KC; Huang SH; Lin CW
    Virus Res; 2019 Nov; 273():197767. PubMed ID: 31560964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.